Prot #2215-CL-0103: A Phase 1 Study of ASP2215 in Combination with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia

Project: Research project

Project Details

StatusActive
Effective start/end date4/15/154/15/21

Funding

  • Astellas Pharma Global Development, Inc. (Prot #2215-CL-0103)